Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma...
Pulmonary DiseaseChronic ObstructiveThis study was designed to test safety aspects and effects on lung function of a new dry powder version of GSK159797 for asthmatic subjects to inhale. This will allow comparison with previous studies which have only used inhalation of the drug as a vapour.
Phase 2 Study - Erdosteine in Patients With CB/COPD
Chronic BronchitisChronic Obstructive Pulmonary DiseaseThis clinical study is designed to explore dose ranging and identify methods to demonstrate the efficacy of Erdosteine in patients with stable Chronic Bronchitis associated with Chronic Obstructive Pulmonary Disease.
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
Pulmonary DiseaseChronic ObstructiveThis study is designed to determine the efficacy and safety of a new long-acting beta-agonist for asthma patients (GSK159797) following dosing for 14 days.
Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate...
Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to assess the tolerability and efficacy of inhaled theophylline (ADC4022) on markers of pulmonary inflammation (white blood cells) in induced sputum and in bronchial biopsy samples in subjects with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) when co-administered with budesonide and compared to placebo.
Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium...
Pulmonary DiseaseChronic ObstructiveThis efficacy and safety study compares four different combinations of blinded inhaled steroid treatments on top of open-label tiotropium and salmeterol in patients with chronic obstructive pulmonary disease (COPD). The primary objective is the effect on lung function parameters.
Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary...
Chronic Obstructive Pulmonary DiseaseThis study will assess the safety and tolerability of QAT370 compared to tiotropium in patients with COPD.
Cognitive Behavioral Therapy for Anxiety and Depression in COPD
AnxietyDepression1 moreThe purpose of this study was to examine the efficacy of manualized, short-term group cognitive behavioral therapy for COPD patients suffering from clinically significant symptoms of anxiety and/or depression.
Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)...
Chronic Obstructive Pulmonary Disease (COPD)This study is to assess the effects with two different inhaled respiratory medications with regards to improvement of lung function, symptoms and morning activities.
Tiotropium and Salmeterol PK Study in COPD Patients
Pulmonary DiseaseChronic ObstructiveThe primary objective of this study is to characterize the pharmacokinetics (i.e. systemic exposure to tiotropium and salmeterol) of tiotropium qd + salmeterol qd or bid versus tiotropium qd and salmeterol bid following 4-week treatment periods in patients with chronic obstructive pulmonary disease (COPD).
Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to elucidate whether combination of usual pulmonary rehabilitation and neuromuscular electrical stimulation of quadriceps may improve exercise capacity in patients affected by chronic obstructive pulmonary disease (COPD).